|
Jul 29
|
Cipher Pharmaceuticals Schedules Q2 2025 Earnings Release and Conference Call
|
|
Jun 13
|
Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders
|
|
May 10
|
Cipher Pharmaceuticals First Quarter 2025 Earnings: Misses Expectations
|
|
Mar 11
|
Cipher Pharmaceuticals Schedules Q4 & Fiscal 2024 Earnings Release and Conference Call
|
|
Oct 8
|
Cipher Pharmaceuticals Enhances Leadership Team with Appointment of New Chief Business Officer
|
|
Sep 24
|
Keynotes and 50 Companies to Present at the Planet MicroCap Showcase: VANCOUVER in association with Small Cap Discoveries on September 25-26, 2024 at the Fairmont Waterfront Vancouver
|
|
Jul 29
|
Cipher Pharmaceuticals Acquires Profitable Growth Dermatology Products from ParaPRO for US$89.5 Million
|
|
Aug 10
|
Cipher Pharmaceuticals Releases Q2 2023 Results, Announces Launch of Epuris in Mexico
|